Daiichinkyo CoDSNKY -1.29%73 Gross Margin % is 48.70% as of Mar. 2026, which is 26% below its 10-year median of 65.61. GuruFocus rates DSNKY with a GF Score™ of 73/100 and a GF Value™ of $37.72 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 935 Drug Manufacturers companies, Daiichinkyo Co ranks better than 80.53% on this metric.
The historical rank and industry rank for Daiichinkyo Co's Gross Margin % or its related term are showing as below:
DSNKY'
s Gross Margin % Range Over the Past 10 Years
Min: 60.78 Med: 65.61 Max: 77.96
Current: 68.49
During the past 13 years, the highestGross Margin % of Daiichinkyo Co was 77.96%. The lowest was 60.78%. And the median was 65.61%.
DSNKY's Gross Margin % is ranked better than 80.53% of 935
companies
in the Drug Manufacturers industry
Industry Median: 48.54
vs DSNKY: 68.49
Daiichinkyo Co had a gross margin of 48.70% for the quarter that ended in Mar. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Daiichinkyo Co was 2.30% per year.
Daiichinkyo Co (OTCPK:DSNKY) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Daiichinkyo Co had a gross margin of 48.70% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Daiichinkyo Co Gross Margin % Related Terms
Daiichinkyo Co Gross Margin % Historical Data
* Premium members only.
The historical data trend for Daiichinkyo Co's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DSNKY vs LLY, JNJ, ABBV: Gross Margin % Comparison
For the Drug Manufacturers - General subindustry, Daiichinkyo Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Daiichinkyo Co Gross Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Daiichinkyo Co's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Daiichinkyo Co's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Daiichinkyo Co (DSNKY) has a Gross Margin % of 48.70% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Daiichinkyo Co and its competitors. This is 26% below median its historical median of 65.61. Over the past decade, Daiichinkyo Co's Gross Margin % has ranged from 60.78 to 77.96. According to the industry distribution chart, Daiichinkyo Co ranks #182 out of 935 companies in the Drug Manufacturers industry, placing it in the top 19.5%.
Is Daiichinkyo Co's Gross Margin % too high?
Daiichinkyo Co's current Gross Margin % of 48.70% is 26% below median its 10-year median of 65.61. Over the past 10 years, this metric has ranged from a low of 60.78 to a high of 77.96. The Drug Manufacturers industry median Gross Margin % is 48.54. Daiichinkyo Co's value of 48.70% is 0.3% above this industry median. Based on the distribution chart, Daiichinkyo Co ranks #182 out of 935 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Daiichinkyo Co has a GF Score™ of 73/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Daiichinkyo Co's Gross Margin % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Daiichinkyo Co ranks #182 out of 935 companies for Gross Margin %. This places Daiichinkyo Co in the top 20% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 48.54. Daiichinkyo Co's value of 48.70% is 0.3% above this benchmark. Historically, Daiichinkyo Co's own Gross Margin % has ranged from 60.78 to 77.96 over the past decade. While the company's 10-year median is 65.61 vs. the industry median of 48.54, Daiichinkyo Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.54, based on 935 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Daiichinkyo Co's current Gross Margin % of 48.70% is 0.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Daiichinkyo Co and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Daiichinkyo Co's current Gross Margin % is 48.70%, which is 26% below median its own 10-year median of 65.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Daiichinkyo Co stock overvalued right now?
Based on GuruFocus' analysis, Daiichinkyo Co (DSNKY) is currently considered Significantly Undervalued. The stock's GF Value™ is $37.72, compared to a current price of $16.02 — trading 57.5% below its estimated fair value. The current Gross Margin % is 48.70%, which is 26% below median its 10-year median of 65.61 and 0.3% above the Drug Manufacturers industry median of 48.54. Daiichinkyo Co's overall GF Score™ is 73/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Daiichinkyo Co (DSNKY), the current Gross Margin % is 48.70% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Daiichinkyo Co (DSNKY) Overvalued in 2026?
Based on GuruFocus' analysis, Daiichinkyo Co stock appears to be undervalued.
The current stock price of $16.02 is trading 57.5% below its estimated GF Value™ of $37.72.
GuruFocus considers Daiichinkyo Co to be Significantly Undervalued.
Key valuation signals for DSNKY:
Gross Margin %: 48.70% (26% below median its 10-year median of 65.61)
GF Value™: $37.72 vs. price of $16.02 (57.5% below fair value)
Industry Position: 0.3% above the Drug Manufacturers median (#182 of 935)
No single metric tells the full story. See the DSNKY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Daiichi Sankyo was established by the merger of Daiichi Pharmaceuticals and Sankyo in 2005. As of 2024, approximately one quarter of revenue comes from its Japan businesses, which will shrink in the future as the company expands its global footprint. Its primary growth driver is its leading platform of antibody drug conjugates, or ADCs. Its lead ADCs are Enhertu (HER2), Datroway (TROP2), I-DXd (B7-H3), HER3-DXd (HER3), and R-DXd (CDH6). Enhertu was first approved in the US in December 2019, and Datroway was first approved in January 2025.
73GF Score
Get the complete analysis for DSNKY
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DSNKY has been successfully added to your 
